[HTML][HTML] Stevens–Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management

R Frantz, S Huang, A Are, K Motaparthi - Medicina, 2021 - mdpi.com
Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare diseases
that are characterized by widespread epidermal necrosis and sloughing of skin. They are …

Worldwide prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

EY Lee, C Knox, EJ Phillips - JAMA dermatology, 2023 - jamanetwork.com
Importance Antibiotics are an important risk for Stevens-Johnson syndrome and toxic
epidermal necrolysis (SJS/TEN), which are the most severe types of drug hypersensitivity …

Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome/toxic epidermal necrolysis—ABCD-10

MH Noe, M Rosenbach, RA Hubbard… - JAMA …, 2019 - jamanetwork.com
Importance Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a spectrum
of severe mucocutaneous drug reaction associated with significant morbidity and mortality. A …

Assessment of treatment approaches and outcomes in Stevens-Johnson syndrome and toxic epidermal necrolysis: insights from a pan-European multicenter study

K Kridin, MC Brüggen, SL Chua, A Bygum… - JAMA …, 2021 - jamanetwork.com
Importance Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are
severe drug reactions associated with a high rate of mortality and morbidity. There is no …

Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults

L Seminario-Vidal, D Kroshinsky… - Journal of the American …, 2020 - Elsevier
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening
conditions with high morbidity and mortality. Supportive care management of SJS/TEN is …

Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review

S Zhang, S Tang, S Li, Y Pan, Y Ding - Journal of Dermatological …, 2020 - Taylor & Francis
Abstract Background: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
is one of severe cutaneous adverse reactions with low morbidity but high mortality. Different …

[HTML][HTML] Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review of PubMed/MEDLINE case reports from 1980 to 2020

L Wang, S Varghese, F Bassir, YC Lo, CA Ortega… - Frontiers in …, 2022 - frontiersin.org
Background Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are
rare, life-threatening immunologic reactions. Prior studies using electronic health records …

HLA‐associated antiepileptic drug‐induced cutaneous adverse reactions

KA Mullan, A Anderson, PT Illing, P Kwan, AW Purcell… - Hla, 2019 - Wiley Online Library
Adverse drug reactions (ADRs) are a common cause of hospital admissions (up to 19%),
with the majority of cases due to off‐target predictable drug effects (type A reactions) …

Systemic therapies for Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN‐based systematic review and meta‐analysis

I Torres‐Navarro, Á Briz‐Redón… - Journal of the …, 2021 - Wiley Online Library
Background The SCORTEN score is a specific predictor of mortality for patients with Stevens–
Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). There is little evidence in …

[HTML][HTML] Updates in SJS/TEN: collaboration, innovation, and community

ME Marks, RK Botta, R Abe, TM Beachkofsky… - Frontiers in …, 2023 - frontiersin.org
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) is a predominantly drug-
induced disease, with a mortality rate of 15–20%, that engages the expertise of multiple …